Cargando…
Mutual potentiation drives synergy between trimethoprim and sulfamethoxazole
Trimethoprim (TMP)-sulfamethoxazole (SMX) is a widely used synergistic antimicrobial combination to treat a variety of bacterial and certain fungal infections. These drugs act by targeting sequential steps in the biosynthetic pathway for tetrahydrofolate (THF), where SMX inhibits production of the T...
Autores principales: | Minato, Yusuke, Dawadi, Surendra, Kordus, Shannon L., Sivanandam, Abiram, Aldrich, Courtney C., Baughn, Anthony D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843663/ https://www.ncbi.nlm.nih.gov/pubmed/29520101 http://dx.doi.org/10.1038/s41467-018-03447-x |
Ejemplares similares
-
Targeting intracellular p-aminobenzoic acid production potentiates the anti-tubercular action of antifolates
por: Thiede, Joshua M., et al.
Publicado: (2016) -
Subversion of Metabolic Wasting as the Mechanism for folM-Linked Sulfamethoxazole Resistance
por: Minato, Yusuke, et al.
Publicado: (2017) -
Methionine Antagonizes para-Aminosalicylic Acid Activity via Affecting Folate Precursor Biosynthesis in Mycobacterium tuberculosis
por: Howe, Michael D., et al.
Publicado: (2018) -
Sulfamethoxazole-Trimethoprim and Hyperkalemia in an Infant
por: Hudzik, Samantha A., et al.
Publicado: (2020) -
Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei
por: Dance, D.A.B., et al.
Publicado: (2014)